Pulmonary Artery Thrombi Located in Opacitated Lung Segments in COVID-19
In patients hospitalized with COVID-19, thrombi in segmental pulmonary arteries are common and are located in opacitated lung segments, which may suggest local clot formation.
Lung Infections
What Is the Value of PCR Testing in COVID-19 Diagnosis?
The use of a PCR test via single nasopharyngeal swab to diagnose SARS-CoV-2 has value but also has demonstrated limitations.
Vaccine Campaign Would Take 6 to 9 Months to Curb COVID-19
When a safe and effective vaccine against COVID-19 becomes available, it is likely to take 6 to 9 months for enough Americans to get vaccinated to have a significant effect on the pandemic.
A New Score to Identify High-Risk, Severe COVID-19 Patients
Researchers identified a prognostic BAS2IC score to assist physicians in identifying patients at high-risk of developing early severe COVID-19.
Early Evidence Suggests No Transmission of SARS-CoV-2 Through Breast Milk
Preliminary evidence suggests infants are unlikely to become infected with SARS-CoV-2 via breast milk.
Racial/Ethnic Variations in Nasal Gene Expression of TMPRSS2 in COVID-19
In patients with COVID-19, nasal gene expression of transmembrane serine protease 2 has demonstrated racial/ethnic variations.
COVID-19: High Through-Put Antibody Assay May Be More Efficient in Diagnosing SARS-CoV-2
A high through-put Luminex antibody assay may provide more accurate results in less time, increasing the efficiency of SARS-CoV-2 diagnosis.
Characteristics Identified in Individuals Younger Than 21 With SARS-CoV-2-Related Deaths
Of individuals aged younger than 21 years with deaths associated with SARS-CoV-2, most are aged 10 to 20 years.
As Tough COVID-19 Summer Ends, Experts Warn of Tougher Fall, Winter
In a sobering illustration of the toll the COVID-19 pandemic took this summer, tallies now show the number of Americans who have died of the infection jumped from just under 100,000 to more than 186,000.
Tocilizumab Reduces Need for Mechanical Ventilation in COVID-19 Pneumonia Trial
Patients treated with tocilizumab were 44% less likely to progress to mechanical ventilation or death compared with placebo.
-
Loading...
-
Loading...
Next post in Critical Care
